Photodynamic therapy: apoptosis, paraptosis and beyond
1Department of Pharmacology, Wayne State University School of Medicine, Detroit, MI, USA. dhkessel@med.wayne.edu.
Apoptosis : an International Journal on Programmed Cell Death
|September 5, 2020
Summary
Photodynamic therapy (PDT) uses light to activate cell-killing compounds, triggering various cell death pathways like apoptosis and paraptosis. Targeted PDT enhances cancer cell destruction by manipulating these pathways and immune responses.
Area of Science:
- Biochemistry
- Cell Biology
- Oncology
Background:
- Photodynamic therapy (PDT) is a light-activated treatment that generates cytotoxic reactive oxygen species.
- PDT can induce multiple programmed cell death pathways, including apoptosis, autophagy, and paraptosis.
- Cellular responses to PDT are complex, involving both cell death and survival mechanisms.
Purpose of the Study:
- To explore the diverse cellular death pathways initiated by photodynamic therapy.
- To investigate the role of sub-cellular targeting in optimizing PDT efficacy.
- To understand how PDT modulates in vivo processes like vascular shutdown and immune response.
Main Methods:
- Review of existing literature on PDT mechanisms.
- Analysis of cellular responses to PDT, including apoptosis, autophagy, and paraptosis.
- Discussion of in vivo effects such as vascular shutdown and immunologic recognition.
Main Results:
- PDT induces various cell death pathways, with apoptosis being the first identified.
- Autophagy can be cytoprotective, while paraptosis can cause cell death even with impaired apoptosis.
- In vivo PDT can lead to vascular shutdown and enhanced anti-tumor immunity.
Conclusions:
- PDT efficacy can be enhanced by directing photosensitizers to specific sub-cellular sites.
- The interplay between different cell death and survival pathways is crucial for photokilling.
- Strategic PDT targeting offers a promising approach for improved cancer therapy.
Related Concept Videos
Overview of Cell Death
8.8K
Cell death is an essential process where the body gets rid of old or damaged cells. Cell proliferation and death need to be balanced, as an imbalance between the two may lead to cancer or autoimmune diseases.
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
8.8K
The Intrinsic Apoptotic Pathway
7.8K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
7.8K
Apoptosis
13.3K
Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size...
13.3K
The Extrinsic Apoptotic Pathway
7.6K
The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
7.6K
Autophagic Cell Death
4.0K
Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
4.0K
Necrosis
5.8K
Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
5.8K


